Form 8-K - Current report:
SEC Accession No. 0001193125-14-245117
Filing Date
2014-06-23
Accepted
2014-06-23 14:27:59
Documents
1
Period of Report
2014-06-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d746054d8k.htm 8-K 12671
  Complete submission text file 0001193125-14-245117.txt   13763
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 14934871
SIC: 2836 Biological Products, (No Diagnostic Substances)